dostawa: Ciltakabtagen autoleucel (nazwa handlowa: CARVYKTI) 3,2 × 106 - 1 × 108 komórek, dyspersja do infuzji
TED · 577702-2026Award noticeawardedNo deadline given
Value
Estimated—
Awarded€373,854 · 1,609,927 PLN
WinnerJanssen-Cilag Polska Sp. z o.o.
Who already wins at this buyer
Firms with recorded awards from Uniwersytecki Szpital Kliniczny w Poznaniu in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| Fresenius Kabi Polska Sp. z o.o. | 2 | €2,539,063 | 2026-08-20 |
| Medicus Sp. z o.o. | 2 | €2,390,105 | 2026-06-16 |
| Urtica Sp. z o.o. | 2 | €466,883 | 2026-06-09 |
| ORS Europe NV Organ Recovery Systems | 1 | €42,966,974 | 2026-06-09 |
| Siemens Healthcare Sp. z o.o. | BIOKOM Diagnostyka Sp. z o.o. | CIRRO Sp. z o.o. | EUROIMMUN POLSKA Sp. z o.o. | Genloxa Sp.z o.o. | Roche Diagnostics Polska Sp. z o.o. | DRG MEDTEK Sp. z o.o. | Werfen Polska Sp. z o.o. | 1 | €2,202,596 | 2026-07-23 |
Full buyer profile: what Uniwersytecki Szpital Kliniczny w Poznaniu buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
dostawa: Ciltakabtagen autoleucel (nazwa handlowa: CARVYKTI) 3,2 × 106 - 1 × 108 komórek, dyspersja do infuzji
Similar tenders
Closest by meaning — across languages, via embeddings.